Quarterly report pursuant to Section 13 or 15(d)

Condensed Statement of Cash Flow

v3.21.2
Condensed Statement of Cash Flow
 7 Months Ended
Sep. 30, 2021
USD ($)
Cash flows from operating activities:  
Net loss $ (666,572)
Adjustments to reconcile net loss to net cash provided by operating activities:  
Offering costs allocated to warrants 505,566
Interest earned on cash and marketable securities held in Trust Account (193)
Changes in current assets and liabilities:  
Prepaid assets (915,147)
Taxes payable 112,329
Due to related party 667
Accrued offering costs and expenses 40,619
Net cash used in operating activities (922,731)
Cash flows from investing activities:  
Principal deposited in Trust Account (234,600,000)
Net cash used in investing activities (234,600,000)
Cash flows from financing activities:  
Proceeds from private placement warrants 11,700,000
Proceeds from initial public offering, net of costs 225,400,000
Proceed from sale of Class B common stock 25,000
Proceeds from issuance of promissory note to related party 110,000
Payment of deferred offering costs (490,543)
Repayment of promissory note to related party (110,000)
Net cash provided by financing activities 236,634,457
Net change in cash 1,111,726
Cash, beginning of the period 0
Cash, end of the period 1,111,726
Supplemental disclosure of non-cash flow financing activities:  
Deferred underwriting commissions payable charged to additional paid in capital 8,050,000
Class A common stock subject to possible redemption 213,225,023
Accretion of carrying value to redemption value 21,374,977
Initial classification of warrant liability $ 17,632,000